Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Dominguez-Escrig JL"'
Autor:
Witjes JA, Babjuk M, Bellmunt J, Bruins HM, De Reijke TM, De Santis M, Gillessen S, James N, Maclennan S, Palou J, Powles T, Ribal MJ, Shariat SF, Van der Kwast T, Xylinas E, Agarwal N, Arends T, Bamias A, Birtle A, Black PC, Bochner BH, Bolla M, Boormans JL, Bossi A, Briganti A, Brummelhuis I, Burger M, Castellano D, Cathomas R, Chiti A, Choudhury A, Comperat E, Crabb S, Culine S, De Bari B, De Blok W, De Visschere PJL, Decaestecker K, Dimitropoulos K, Dominguez-Escrig JL, Fanti S, Fonteyne V, Frydenberg M, Futterer JJ, Gakis G, Geavlete B, Gontero P, Grubmuller B, Hafeez S, Hansel DE, Hartmann A, Hayne D, Henry AM, Hernandez V, Herr H, Herrmann K, Hoskin P, Huguet J, Jereczek-Fossa BA, Jones R, Kamat AM, Khoo V, Kiltie AE, Krege S, Ladoire S, Lara PC, Leliveld A, Linares-Espinos E, Logager V, Lorch A, Loriot Y, Meijer R, Mir MC, Moschini M, Mostafid H, Muller AC, Muller CR, N'Dow J, Necchi A, Neuzillet Y, Oddens JR, Oldenburg J, Osanto S, Oyen WJG, Pacheco-Figueiredo L, Pappot H, Patel MI, Pieters BR, Plass K, Remzi M, Retz M, Richenberg J, Rink M, Roghmann F, Rosenberg JE, Roupret M, Rouviere O, Salembier C, Salminen A, Sargos P, Sengupta S, Sherif A, Smeenk RJ, Smits A, Stenzl A, Thalmann GN, Tombal B, Turkbey B, Lauridsen SV, Valdagni R, Van der Heijden AG, Van Poppel H, Vartolomei MD, Veskimae E, Vilaseca A, Rivera FAV, Wiegel T, Wiklund P, Williams A, Zigeuner R, Horwich A
Publikováno v:
European Urology, 77(2), 223-250. ELSEVIER
European urology, Vol. 77, no. 2, p. 223-250 (2020)
European urology, Vol. 77, no. 2, p. 223-250 (2020)
Background: Although guidelines exist for advanced and variant bladder cancer management, evidence is limited/conflicting in some areas and the optimal approach remains controversial.Objective: To bring together a large multidisciplinary group of exp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::83ca5ce68e8f6ca0b1afbd566e3b92bc
https://doi.org/10.1016/j.eururo.2019.09.035
https://doi.org/10.1016/j.eururo.2019.09.035
Autor:
Alvarez-Maestro, M, Guerrero-Ramos, F, Rodriguez-Faba, O, Dominguez-Escrig, JL, Fernandez-Gomez, JM
Publikováno v:
Actas Urologicas Espanolas
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Universitat Politècnica de Catalunya (UPC)
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Universitat Politècnica de Catalunya (UPC)
The treatment of choice for high-risk non-muscle invasive bladder cancer (NMIBC) is bacillus Calmette-Guerin (BCG). However, when this fails, the indicated treatment is radical cystectomy. In recent years, trials are being developed with various drug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::59a70d031bc6f1e3438e15124c821068
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=11814
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=11814
Background: Although guidelines exist for advanced and variant bladder cancer management, evidence is limited/conflicting in some areas and the optimal approach remains controversial. Objective: To bring together a large multidisciplinary group of ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4094::5f38d4d41e552aac8431ffc4bee13521
http://hdl.handle.net/11585/801900
http://hdl.handle.net/11585/801900
Autor:
Seisen, T, Peyronnet, B, Dominguez-Escrig, JL, Bruins, HM, Yuan, CY, Babjuk, M, Bohle, A, Burger, M, Comperat, EM, Cowan, NC, Kaasinen, E, Palou, J, van Rhijn, BWG, Sylvester, RJ, Zigeuner, R, Shariat, SF, Roupret, M
Publikováno v:
EUROPEAN UROLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Context: There is uncertainty regarding the oncologic effectiveness of kidney-sparing surgery (KSS) compared with radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC). Objective: To systematically review the current literature
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::bde7a2713e4619c81293a760dd8ad702
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6881
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6881
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Antoine G. van der Heijden, Konstantinos Dimitropoulos, Joost L. Boormans, Bogdan Geavlete, Iris Brummelhuis, Andrew K. Williams, Christoph R. Müller, Susanne Vahr Lauridsen, Arturo Chiti, Manish I. Patel, Jonathan E. Rosenberg, Baris Turkbey, Carl Salembier, Thomas Wiegel, Anja Lorch, Valérie Fonteyne, Willem de Blok, Evanguelos Xylinas, Antti Salminen, Ann Henry, Karin Plass, Amir Sherif, Hugh Mostafid, Peter Wiklund, Erik Veskimäe, Hein Van Poppel, Max Bürger, Juan Palou, J. Domínguez-Escrig, Karel Decaestecker, Morgan Rouprêt, Helle Pappot, Paul Sargos, Berardino De Bari, Riccardo Valdagni, Luís Pacheco-Figueiredo, Jorge Huguet, Silke Gillessen, Olivier Rouvière, Maria J. Ribal, Yann Neuzillet, Richard Cathomas, Shaista Hafeez, Robert Jan Smeenk, Mark Frydenberg, Marek Babjuk, Antoni Vilaseca, Maria De Santis, Jonathan Richenberg, Annemarie Leliveld, Tom J.H. Arends, Shomik Sengupta, Vibeke Løgager, Harry W. Herr, Wim J.G. Oyen, Ananya Choudhury, Nicholas D. James, Susanne Osanto, Shahrokh F. Shariat, Vincent Khoo, A. Müller, Neeraj Agarwal, Pieter De Visschere, Bradley R. Pieters, Alberto Briganti, Robert Jones, Peter C. Black, Alberto Bossi, H. Maxim Bruins, Richard P. Meijer, Bertrand Tombal, Ken Herrmann, Donna E. Hansel, M. Carmen Mir, Stéphane Culine, J. Alfred Witjes, Virginia Hernández, Joaquim Bellmunt, Arnulf Stenzl, Eva Compérat, Alan Horwich, Alison Birtle, Jorg R. Oddens, Bernhard Grubmüller, Margitta Retz, Sylvain Ladoire, Marco Moschini, Aristotle Bamias, Simon J. Crabb, Michel Bolla, Theo H. van der Kwast, Steven MacLennan, Michael Rink, Anita Smits, Yohann Loriot, Estefania Linares-Espinós, James N'Dow, Theo M. de Reijke, Thomas Powles, Jurgen J. Fütterer, Arndt Hartmann, Daniel Castellano, Mesut Remzi, Paolo Gontero, Dickon Hayne, Anne E. Kiltie, Richard Zigeuner, Georgios Gakis, Franklin A. Vives Rivera, Stefano Fanti, Susanne Krege, Pedro C. Lara, Mihai Dorin Vartolomei, Ashish M. Kamat, Jan Oldenburg, Peter Hoskin, Andrea Necchi, Barbara Alicja Jereczek-Fossa, George N. Thalmann, Bernard H. Bochner, Florian Roghmann
Publikováno v:
Annals of Oncology, 30(11), 1697-1727. Oxford University Press
Annals of Oncology, 30(11), 1697-1727. OXFORD UNIV PRESS
Ann Oncol
Horwich, A, Babjuk, M, Bellmunt, J, Bruins, H M, de Reijke, T M, de Santis, M, Gillessen, S, James, N, Maclennan, S, Palou, J, Powles, T, Ribal, M J, Shariat, S F, van der Kwast, T, Xylinas, E, Agarwal, N, Arends, T, Bamias, A, Birtle, A, Black, P C, Bochner, B H, Bolla, M, Boormans, J L, Bossi, A, Briganti, A, Brummelhuis, I, Burger, M, Castellano, D, Cathomas, R, Chiti, A, Choudhury, A, Compérat, E, Crabb, S, Culine, S, de Bari, B, DeBlok, W, de Visschere, P J L, Decaestecker, K, Dimitropoulos, K, Dominguez-Escrig, J L, Fanti, S, Fonteyne, V, Frydenberg, M, Futterer, J J, Gakis, G, Geavlete, B, Gontero, P, Grubmüller, B, Hafeez, S, Hansel, D E, Hartmann, A, Hayne, D, Henry, A M, Hernandez, V, Herr, H, Herrmann, K, Hoskin, P, Huguet, J, Jereczek-Fossa, B A, Jones, R, Kamat, A M, Khoo, V, Kiltie, A E, Krege, S, Ladoire, S, Lara, P C, Leliveld, A, Linares-Espinós, E, Løgager, V, Lorch, A, Loriot, Y, Meijer, R, Carmen Mir, M, Moschini, M, Mostafid, H, Müller, A C, Müller, C R, N'Dow, J, Necchi, A, Neuzillet, Y, Oddens, J R, Oldenburg, J, Osanto, S, Oyen, W J G, Pacheco-Figueiredo, L, Pappot, H, Patel, M I, Pieters, B R, Plass, K, Remzi, M, Retz, M, Richenberg, J, Rink, M, Roghmann, F, Rosenberg, J E, Rouprêt, M, Rouvière, O, Salembier, C, Salminen, A, Sargos, P, Sengupta, S, Sherif, A, Smeenk, R J, Smits, A, Stenzl, A, Thalmann, G N, Tombal, B, Turkbey, B, Vahr Lauridsen, S, Valdagni, R, van der Heijden, A G, van Poppel, H, Vartolomei, M D, Veskimäe, E, Vilaseca, A, Vives Rivera, F A, Wiegel, T, Wiklund, P, Williams, A, Zigeuner, R & Witjes, J A 2019, ' EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees ', Annals of Oncology, vol. 30, no. 11, pp. 1697-1727 . https://doi.org/10.1093/annonc/mdz296
Annals of Oncology
Annals of Oncology, 30(11), 1697. Oxford University Press
Annals of oncology, 30(11), 1697-1727. Oxford University Press
Annals of Oncology, Vol. 30, no. 11, p. 1697-17 (2019)
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Annals of Oncology, 30(11), 1697-1727. Elsevier Ltd.
Annals of Oncology, 30, 1697-1727
Annals of Oncology, 30, 11, pp. 1697-1727
Annals of Oncology, 30(11), 1697-1727. OXFORD UNIV PRESS
Ann Oncol
Horwich, A, Babjuk, M, Bellmunt, J, Bruins, H M, de Reijke, T M, de Santis, M, Gillessen, S, James, N, Maclennan, S, Palou, J, Powles, T, Ribal, M J, Shariat, S F, van der Kwast, T, Xylinas, E, Agarwal, N, Arends, T, Bamias, A, Birtle, A, Black, P C, Bochner, B H, Bolla, M, Boormans, J L, Bossi, A, Briganti, A, Brummelhuis, I, Burger, M, Castellano, D, Cathomas, R, Chiti, A, Choudhury, A, Compérat, E, Crabb, S, Culine, S, de Bari, B, DeBlok, W, de Visschere, P J L, Decaestecker, K, Dimitropoulos, K, Dominguez-Escrig, J L, Fanti, S, Fonteyne, V, Frydenberg, M, Futterer, J J, Gakis, G, Geavlete, B, Gontero, P, Grubmüller, B, Hafeez, S, Hansel, D E, Hartmann, A, Hayne, D, Henry, A M, Hernandez, V, Herr, H, Herrmann, K, Hoskin, P, Huguet, J, Jereczek-Fossa, B A, Jones, R, Kamat, A M, Khoo, V, Kiltie, A E, Krege, S, Ladoire, S, Lara, P C, Leliveld, A, Linares-Espinós, E, Løgager, V, Lorch, A, Loriot, Y, Meijer, R, Carmen Mir, M, Moschini, M, Mostafid, H, Müller, A C, Müller, C R, N'Dow, J, Necchi, A, Neuzillet, Y, Oddens, J R, Oldenburg, J, Osanto, S, Oyen, W J G, Pacheco-Figueiredo, L, Pappot, H, Patel, M I, Pieters, B R, Plass, K, Remzi, M, Retz, M, Richenberg, J, Rink, M, Roghmann, F, Rosenberg, J E, Rouprêt, M, Rouvière, O, Salembier, C, Salminen, A, Sargos, P, Sengupta, S, Sherif, A, Smeenk, R J, Smits, A, Stenzl, A, Thalmann, G N, Tombal, B, Turkbey, B, Vahr Lauridsen, S, Valdagni, R, van der Heijden, A G, van Poppel, H, Vartolomei, M D, Veskimäe, E, Vilaseca, A, Vives Rivera, F A, Wiegel, T, Wiklund, P, Williams, A, Zigeuner, R & Witjes, J A 2019, ' EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees ', Annals of Oncology, vol. 30, no. 11, pp. 1697-1727 . https://doi.org/10.1093/annonc/mdz296
Annals of Oncology
Annals of Oncology, 30(11), 1697. Oxford University Press
Annals of oncology, 30(11), 1697-1727. Oxford University Press
Annals of Oncology, Vol. 30, no. 11, p. 1697-17 (2019)
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Annals of Oncology, 30(11), 1697-1727. Elsevier Ltd.
Annals of Oncology, 30, 1697-1727
Annals of Oncology, 30, 11, pp. 1697-1727
Although guidelines exist for advanced and variant bladder cancer management, evidence is limited/conflicting in some areas and the optimal approach remains controversial. Background: Although guidelines exist for advanced and variant bladder cancer
Autor:
Gontero P; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy. Electronic address: paolo.gontero@unito.it., Birtle A; Rosemere Cancer Centre, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK., Capoun O; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic., Compérat E; Department of Pathology, Medical University of Vienna, Vienna, Austria., Dominguez-Escrig JL; Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain., Liedberg F; Institute of Translational Medicine, Lund University, Malmö, Sweden; Department of Urology, Skåne University Hospital, Malmö, Sweden., Mariappan P; Edinburgh Bladder Cancer Surgery (EBCS), Western General Hospital, The University of Edinburgh, Edinburgh, UK., Masson-Lecomte A; Department of Urology, APHP, Saint Louis Hospital, Université de Paris, Paris, France., Mostafid HA; Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK., Pradere B; Department of Urology, La Croix Du Sud Hospital, Quint Fonsegrives, France., Rai BP; Department of Urology, Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., van Rhijn BWG; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Seisen T; Urology, GRC 5 Predictive Onco-Uro, AP-HP, Pitie-Salpetriere Hospital, Sorbonne University, Paris, France., Shariat SF; Department of Urology, Comprehensive Cancer Center, Vienna General Hospital, Medical University Vienna, Vienna, Austria., Soria F; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy., Soukup V; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic., Wood R; EAU Guidelines Office, Arnhem, The Netherlands., Xylinas EN; Department of Urology, Bichat-Claude Bernard Hospital, AP-HP, Université de Paris, Paris, France.
Publikováno v:
European urology [Eur Urol] 2024 Aug 17. Date of Electronic Publication: 2024 Aug 17.
Autor:
Beijert IJ; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands., Hentschel AE; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands., Bründl J; Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany., Compérat EM; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Pathology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France., Plass K; European Association of Urology, Guidelines Office Board, Arnhem, The Netherlands., Rodríguez O; Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain., Subiela Henríquez JD; Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain., Hernández V; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain., de la Peña E; Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain., Alemany I; Pathology, Hospital Universitario Fundación Alcorcón, Madrid, Spain., Turturica D; Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Turin, Italy., Pisano F; Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Turin, Italy., Soria F; Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Turin, Italy., Čapoun O; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic., Bauerová L; Pathology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic., Pešl M; Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic., Bruins HM; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, Radboud University Medical Center, Nijmegen, The Netherlands.; Urology, Zuyderland Medical Center, Sittard/Heerlen, The Netherlands., Runneboom W; Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Herdegen S; Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany., Breyer J; Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany., Brisuda A; Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic., Calatrava A; Pathology, Fundación Instituto Valenciano de Oncología (I.V.O.), Valencia, Spain., Rubio-Briones J; Urology, Fundación Instituto Valenciano de Oncología (I.V.O.), Valencia, Spain., Seles M; Urology, Medical University of Graz, Graz, Austria., Mannweiler S; Pathology, Medical University of Graz, Graz, Austria., Bosschieter J; Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands., Kusuma VRM; Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK., Ashabere D; Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK., Huebner N; Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria., Cotte J; Urology, Pitié Salpétrière Hospital, AP-HP, GRC no 5, ONCOTYPE-URO, Sorbonne University, 75013, Paris, France., Contieri R; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Mertens LS; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Claps F; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Masson-Lecomte A; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands., Liedberg F; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands., Cohen D; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, Royal Free London-NHS Foundation Trust, Royal Free Hospital, London, UK., Lunelli L; Urology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France., Cussenot O; Urology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France., El Sheikh S; Pathology, Royal Free London-NHS Foundation Trust, Royal Free Hospital, London, UK., Volanis D; Urology, Royal Free London-NHS Foundation Trust, Royal Free Hospital, London, UK., Côté JF; Pathology, Pierre et Marie Curie Medical School, Pitié Salpétrière Hospital, AP-HP, Sorbonne University, Paris, France., Rouprêt M; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, Pitié Salpétrière Hospital, AP-HP, GRC no 5, ONCOTYPE-URO, Sorbonne University, 75013, Paris, France., Haitel A; Pathology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria., Shariat SF; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria., Mostafid AH; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK., Nieuwenhuijzen JA; Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands., Zigeuner R; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, Medical University of Graz, Graz, Austria., Dominguez-Escrig JL; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, Fundación Instituto Valenciano de Oncología (I.V.O.), Valencia, Spain., Hacek J; Pathology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic., Zlotta AR; Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada., Burger M; Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands., Evert M; Pathology, University of Regensburg, Regensburg, Germany., Hulsbergen-van de Kaa CA; Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., van der Heijden AG; Urology, Radboud University Medical Center, Nijmegen, The Netherlands., Kiemeney LALM; Health Evidence and Urology, Radboud University Medical Center, Nijmegen, The Netherlands., Soukup V; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic., Molinaro L; Pathology, Città della Salute e della Scienza, University of Torino School of Medicine, Turin, Italy., Gontero P; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Turin, Italy., Llorente C; Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain., Algaba F; Pathology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain., Palou J; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain., N'Dow J; European Association of Urology, Guidelines Office Board, Arnhem, The Netherlands., Ribal MJ; European Association of Urology, Guidelines Office Board, Arnhem, The Netherlands., van der Kwast TH; Laboratory Medicine Program, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada., Babjuk M; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria., Sylvester RJ; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands., van Rhijn BWG; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. b.v.rhijn@nki.nl.; Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany. b.v.rhijn@nki.nl.; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands. b.v.rhijn@nki.nl.; Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada. b.v.rhijn@nki.nl.
Publikováno v:
International urology and nephrology [Int Urol Nephrol] 2024 Apr; Vol. 56 (4), pp. 1323-1333. Date of Electronic Publication: 2023 Nov 19.
Autor:
Subiela JD; Department of Urology, Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcala, Madrid, Spain. Electronic address: jdsubiela@gmail.com., Krajewski W; Department of Minimally Invasive Robotic Urology, Center of Excellence in Urology, Wrocław Medical University, Wrocław, Poland., González-Padilla DA; Department of Urology, Clínica Universidad de Navarra, Madrid, Spain., Laszkiewicz J; Department of Minimally Invasive Robotic Urology, Center of Excellence in Urology, Wrocław Medical University, Wrocław, Poland., Taborda J; Department of Urology, Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcala, Madrid, Spain., Aumatell J; Servicio de Urología, Hospital Universitario Rey Juan Carlos, Universidad Rey Juan Carlos Móstoles, Madrid, Spain., Sanchez Encinas M; Servicio de Urología, Hospital Universitario Rey Juan Carlos, Universidad Rey Juan Carlos Móstoles, Madrid, Spain., Basile G; Division of Experimental Oncology, Department of Urology, Urological Research Institute, Vita-Salute San Raffaele University, Milan, Italy., Moschini M; Division of Experimental Oncology, Department of Urology, Urological Research Institute, Vita-Salute San Raffaele University, Milan, Italy., Caño-Velasco J; Department of Urology, Hospital Universitario Gregorio Marañon, Madrid, Spain., Lopez Perez E; Department of Urology, Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcala, Madrid, Spain., Del Olmo Durán P; Department of Urology, Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcala, Madrid, Spain., Gallioli A; Department of Urology, Fundaciò Puigvert, Autonomous University of Barcelona, Barcelona, Spain., Tukiendorf A; Institute of Health Sciences, Opole University, Opole, Poland; University Clinical Hospital in Opole, Opole, Poland., D'Andrea D; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Yuen-Chun Teoh J; S.H. Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Shatin, Hong Kong Special Administrative Region., Serna Céspedes A; Department of Urology, Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcala, Madrid, Spain., Pichler R; Medical University of Innsbruck, Department of Urology, Comprehensive Cancer Center Innsbruck (CCCI), Innsbruck, Austria., Afferi L; Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland., Del Giudice F; Department of Maternal-Infant and Urological Sciences, Policlinico Umberto I Hospital, 'Sapienza' University of Rome, Rome, Italy., Gomez Rivas J; Department of Urology, Hospital Clínico San Carlos, Madrid, Spain., Albisinni S; Urology Unit, Department of Surgical Sciences, Tor Vergata University Hospital, University of Rome Tor Vergata, Rome, Italy., Soria F; Division of Urology, Department of Surgical Sciences Molinette Hospital University of Torino School of Medicine, Torino, Italy., Ploussard G; Department of Urology, La Croix du Sud Hospital, Quint Fonsegrives, France., Mertens LS; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Rajwa P; Department of Urology, Medical University of Silesia, Zabrze, Poland., Laukhtina E; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia., Pradere B; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, La Croix du Sud Hospital, Quint Fonsegrives, France., Tully K; Department of Urology and Neurourology, Marien Hospital Herne, Ruhr-University Bochum, Herne, Germany., Guerrero-Ramos F; Department of Urology, Hospital Universitario 12 de Octubre, Madrid, Spain; ROC Clinic, Madrid, Spain; Department of Urology, Hospital Universitario HM Sanchinarro, Madrid, Spain., Rodríguez-Faba Ó; Department of Urology, Fundaciò Puigvert, Autonomous University of Barcelona, Barcelona, Spain., Alvarez-Maestro M; Department of Urology, Hospital Universitario La Paz, Madrid, Spain., Dominguez-Escrig JL; Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain., Szydełko T; Department of Minimally Invasive Robotic Urology, Center of Excellence in Urology, Wrocław Medical University, Wrocław, Poland., Gomez Dos Santos V; Department of Urology, Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcala, Madrid, Spain., Jiménez Cidre MÁ; Department of Urology, Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcala, Madrid, Spain., Burgos Revilla FJ; Department of Urology, Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcala, Madrid, Spain.
Publikováno v:
European urology oncology [Eur Urol Oncol] 2024 Feb 13. Date of Electronic Publication: 2024 Feb 13.
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update.
Autor:
Rouprêt M; GRC 5 Predictive Onco-Uro, Sorbonne University, AP-HP, Urology, Pitie-Salpetriere Hospital, Paris, France. Electronic address: morgan.roupret@aphp.fr., Seisen T; GRC 5 Predictive Onco-Uro, Sorbonne University, AP-HP, Urology, Pitie-Salpetriere Hospital, Paris, France., Birtle AJ; Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK; University of Manchester, Manchester, UK., Capoun O; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czechia; Department of Pathology, General Hospital of Vienna, Medical University of Vienna, Vienna, Austria., Compérat EM; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czechia; Department of Pathology, General Hospital of Vienna, Medical University of Vienna, Vienna, Austria; Department of Pathology, Sorbonne University, AP-HP, Hôpital Tenon, Paris., Dominguez-Escrig JL; Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain., Gürses Andersson I; Patient advocate, Bladder Cancer Norway, Norway., Liedberg F; Department of Translational Medicine, Lund University, Malmö, Sweden; Department of Urology, Skåne University Hospital, Malmö, Sweden., Mariappan P; Department of Urology, Edinburgh Bladder Cancer Surgery, Western General Hospital, Edinburgh, UK., Hugh Mostafid A; Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK., Pradere B; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, La Croix Du Sud Hospital, Quint Fonsegrives, France., van Rhijn BWG; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Shariat SF; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czechia; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria., Rai BP; Department of Urology, Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Soria F; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy., Soukup V; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czechia; Department of Pathology, General Hospital of Vienna, Medical University of Vienna, Vienna, Austria., Wood RG; Patient advocate, Bladder Cancer Norway, Norway., Xylinas EN; Department of Urology, Bichat-Claude Bernard Hospital, AP-HP, Université de Paris, Paris, France., Masson-Lecomte A; Department of Urology, Université de Paris, AP-HP, Saint Louis Hospital, Paris, France., Gontero P; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.
Publikováno v:
European urology [Eur Urol] 2023 Jul; Vol. 84 (1), pp. 49-64. Date of Electronic Publication: 2023 Mar 24.